Cargando…

Troponin T Elevation After Percutaneous Left Atrial Appendage Occlusion

Background: Cardiac troponin T (cTNT) has been widely used in detecting cardiac damage. Elevated cTNT level has been reported to be associated with increased mortality in multiple cardiac conditions. It is not uncommon to observe an increased level of cTNT in patients after left atrial appendage occ...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xiaoyan, Chen, Xueying, Ye, Yong, Peng, Juan, Lin, Jinyi, Deng, Xin, Lin, Li, You, Jieyun, Wang, Xingxu, Zhou, Daxin, Chen, Qingxing, Ge, Junbo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8517138/
https://www.ncbi.nlm.nih.gov/pubmed/34660722
http://dx.doi.org/10.3389/fcvm.2021.721224
_version_ 1784583947747852288
author Wang, Xiaoyan
Chen, Xueying
Ye, Yong
Peng, Juan
Lin, Jinyi
Deng, Xin
Lin, Li
You, Jieyun
Wang, Xingxu
Zhou, Daxin
Chen, Qingxing
Ge, Junbo
author_facet Wang, Xiaoyan
Chen, Xueying
Ye, Yong
Peng, Juan
Lin, Jinyi
Deng, Xin
Lin, Li
You, Jieyun
Wang, Xingxu
Zhou, Daxin
Chen, Qingxing
Ge, Junbo
author_sort Wang, Xiaoyan
collection PubMed
description Background: Cardiac troponin T (cTNT) has been widely used in detecting cardiac damage. Elevated cTNT level has been reported to be associated with increased mortality in multiple cardiac conditions. It is not uncommon to observe an increased level of cTNT in patients after left atrial appendage occlusion (LAAO). The objective of the study is to study the incidence, significance, and factors associated with cTNT elevation after LAAO. Methods: We prospectively included patients who underwent LAAO from January 2019 to July 2020 in Fudan Zhongshan Hospital. Patients were divided into those with elevated cTNT after procedure and those with normal postprocedure cTNT. All individuals were followed up for 1 year. The primary outcome is major adverse cardiovascular events, which include myocardial infarction, heart failure, cardiac death, and stroke. The second outcome is periprocedure complication, including chest pain, tachycardia, cardiac tamponade, change of electrocardiograph, and atrial thrombus. Results: A total of 190 patients were enrolled. Of the patients, 85.3% had elevated cTNT after LAAO, while 14.7% of them did not. Exposure time, dosage of contrast, types of devices, shapes, and sizes of LAA could contribute to elevated postprocedure cTNT. We found that patients with a Watchman device were more likely to have elevated postprocedure cTNT than those with a Lambre device (89.2 vs. 76.7%, p = 0.029). LAAO shapes were associated with cTNT levels in patients with a Watchman device, while the diameter of the outer disc and LAA depth mattered for the Lambre device. There was no significant difference in the primary and second outcome between the two groups (p-value: 0.619, 0.674). Conclusion: LAAO was found to be commonly accompanied with cTNT elevation, which might not to be related to the complications and adverse cardiac outcomes within 1 year of follow-up. Moreover, eGFR at baseline, exposure time, dosage of contrast, types of LAAO device, and LAA morphology could contribute to cTNT elevation.
format Online
Article
Text
id pubmed-8517138
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-85171382021-10-16 Troponin T Elevation After Percutaneous Left Atrial Appendage Occlusion Wang, Xiaoyan Chen, Xueying Ye, Yong Peng, Juan Lin, Jinyi Deng, Xin Lin, Li You, Jieyun Wang, Xingxu Zhou, Daxin Chen, Qingxing Ge, Junbo Front Cardiovasc Med Cardiovascular Medicine Background: Cardiac troponin T (cTNT) has been widely used in detecting cardiac damage. Elevated cTNT level has been reported to be associated with increased mortality in multiple cardiac conditions. It is not uncommon to observe an increased level of cTNT in patients after left atrial appendage occlusion (LAAO). The objective of the study is to study the incidence, significance, and factors associated with cTNT elevation after LAAO. Methods: We prospectively included patients who underwent LAAO from January 2019 to July 2020 in Fudan Zhongshan Hospital. Patients were divided into those with elevated cTNT after procedure and those with normal postprocedure cTNT. All individuals were followed up for 1 year. The primary outcome is major adverse cardiovascular events, which include myocardial infarction, heart failure, cardiac death, and stroke. The second outcome is periprocedure complication, including chest pain, tachycardia, cardiac tamponade, change of electrocardiograph, and atrial thrombus. Results: A total of 190 patients were enrolled. Of the patients, 85.3% had elevated cTNT after LAAO, while 14.7% of them did not. Exposure time, dosage of contrast, types of devices, shapes, and sizes of LAA could contribute to elevated postprocedure cTNT. We found that patients with a Watchman device were more likely to have elevated postprocedure cTNT than those with a Lambre device (89.2 vs. 76.7%, p = 0.029). LAAO shapes were associated with cTNT levels in patients with a Watchman device, while the diameter of the outer disc and LAA depth mattered for the Lambre device. There was no significant difference in the primary and second outcome between the two groups (p-value: 0.619, 0.674). Conclusion: LAAO was found to be commonly accompanied with cTNT elevation, which might not to be related to the complications and adverse cardiac outcomes within 1 year of follow-up. Moreover, eGFR at baseline, exposure time, dosage of contrast, types of LAAO device, and LAA morphology could contribute to cTNT elevation. Frontiers Media S.A. 2021-10-01 /pmc/articles/PMC8517138/ /pubmed/34660722 http://dx.doi.org/10.3389/fcvm.2021.721224 Text en Copyright © 2021 Wang, Chen, Ye, Peng, Lin, Deng, Lin, You, Wang, Zhou, Chen and Ge. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cardiovascular Medicine
Wang, Xiaoyan
Chen, Xueying
Ye, Yong
Peng, Juan
Lin, Jinyi
Deng, Xin
Lin, Li
You, Jieyun
Wang, Xingxu
Zhou, Daxin
Chen, Qingxing
Ge, Junbo
Troponin T Elevation After Percutaneous Left Atrial Appendage Occlusion
title Troponin T Elevation After Percutaneous Left Atrial Appendage Occlusion
title_full Troponin T Elevation After Percutaneous Left Atrial Appendage Occlusion
title_fullStr Troponin T Elevation After Percutaneous Left Atrial Appendage Occlusion
title_full_unstemmed Troponin T Elevation After Percutaneous Left Atrial Appendage Occlusion
title_short Troponin T Elevation After Percutaneous Left Atrial Appendage Occlusion
title_sort troponin t elevation after percutaneous left atrial appendage occlusion
topic Cardiovascular Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8517138/
https://www.ncbi.nlm.nih.gov/pubmed/34660722
http://dx.doi.org/10.3389/fcvm.2021.721224
work_keys_str_mv AT wangxiaoyan troponintelevationafterpercutaneousleftatrialappendageocclusion
AT chenxueying troponintelevationafterpercutaneousleftatrialappendageocclusion
AT yeyong troponintelevationafterpercutaneousleftatrialappendageocclusion
AT pengjuan troponintelevationafterpercutaneousleftatrialappendageocclusion
AT linjinyi troponintelevationafterpercutaneousleftatrialappendageocclusion
AT dengxin troponintelevationafterpercutaneousleftatrialappendageocclusion
AT linli troponintelevationafterpercutaneousleftatrialappendageocclusion
AT youjieyun troponintelevationafterpercutaneousleftatrialappendageocclusion
AT wangxingxu troponintelevationafterpercutaneousleftatrialappendageocclusion
AT zhoudaxin troponintelevationafterpercutaneousleftatrialappendageocclusion
AT chenqingxing troponintelevationafterpercutaneousleftatrialappendageocclusion
AT gejunbo troponintelevationafterpercutaneousleftatrialappendageocclusion